The magnitude of exercise-induced weight loss depends on the extent of compensatory responses. An increase in energy intake is likely to result from changes in the appetite control system toward an orexigenic environment; however, few studies have measured how exercise impacts on both orexigenic and anorexigenic peptides.
cise increase their eating and do not lose as much weight as expected" (4) . It is generally accepted that the appetite regulatory system will quickly defend impositions that promote a negative energy balance (EB). Metabolic and behavioral compensatory responses, targeting both sides of the EB equation, are likely to influence the magnitude of weight loss in response to exercise. Individual variability in those compensatory responses could partly explain interindividual variation in exercise-induced weight loss and why some individuals fail to lose weight with exercise (5) . It has been proposed that the difficulty in maintaining EB in a weight-reduced state is a consequence of a "compromised appetite control." Weight loss may lead to counterregulatory adaptations, possibly through up-regulation of orexigenic (ghrelin) and down-regulation of anorexigenic [polypeptide YY (PYY) and glucagon-like peptide-1 (GLP-1)] peptides (6) . These peptides are expected to serve as food cues and modulate the expression of feeding behavior by increasing hunger and energy intake (EI), in an attempt to automatically restore EB and prevent further weight loss.
We have recently shown that participants who lose less weight than expected in response to a supervised exercise program experience a compensatory increase in habitual EI accompanied by an increased drive to eat (3) . The increase in EI experienced by some in response to an imposed exercise program could theoretically be driven by an increase in the release of ghrelin, an orexigenic peptide, and/or a blunted release of satiety gut peptides in response to a fixed meal.
Not much research has been devoted to the impact of long-term exercise on the release of appetite-related hormones in the obese population and how that relates to weight loss (7) . Although it has already been shown that exercise-induced weight loss induces a compensatory increase in total ghrelin (TG) plasma levels (8 -10) , no significant changes have been reported on acylated ghrelin (AG) (10, 11) . This is the molecular form that is able to bind to the GH secretagogue receptor, cross the bloodbrain barrier, and therefore exert its orexigenic effects at the hypothalamic level. However, the previous two studies were performed in children and adolescents, and in the latter study no significant changes in body weight were observed (11) . Evidence regarding the impact of chronic exercise on the plasma levels of satiety gut peptides is also relatively scarce, particularly in the obese population. However, two studies in adolescents have reported an increase in the release of satiety peptides in response to medium-to long-term exercise (11, 12) .
The aim of this study was to investigate the effects of a 12-wk supervised exercise program on fasting and postprandial plasma levels of appetite-related hormones and the subjective feelings of appetite in sedentary overweight/ obese individuals and to determine whether any changes were correlated with the magnitude of exercise-induced weight loss.
Subjects and Methods

Participants
Twenty-two overweight and obese healthy sedentary volunteers (eight men and 14 women) were recruited for this study through advertisements posted at the university and surrounding community. Inclusion criteria were as follows: age between 18 and 60 yr; body mass index (BMI) between 27 and 35 kg/m 2 ; weight stable (Ͻ2-kg variation in body weight for the last 3 months); not currently dieting to lose weight; not taking any medication known to affect body weight or appetite; a sedentary lifestyle; and a restraint score of 12 or less derived from the Three Factor Eating Behavior Questionnaire (TFEQ) (13) . Sedentary lifestyle was defined as not engaged in strenuous work or in regular brisk leisure physical activity more than once a week or in light exercise for more than 20 min/d more than three times per week and was assessed through an exercise history relating to the 3 months before the study.
This study was conducted according to the guidelines laid down in the Declaration of Helsinki. All participants gave written consent before enrolling in the study, and approval was obtained from the regional Ethics Committee (Midt-Norge, Trondheim, Norway).
Study protocol
Participants underwent a 12-wk supervised exercise program and were asked to maintain their normal diet throughout the study. Several measurements were performed before and after the intervention, including: body weight and composition, maximal oxygen consumption (VO 2 max), resting metabolic rate, habitual food intake, fasting and postprandial release of appetiterelated hormones, and subjective feelings of appetite.
Exercise program
Participants underwent a 12-wk exercise program (5 d/wk) consisting of treadmill walking or running. The program was individually designed to induce a 500-kcal energy deficit per session at approximately 75% of their maximal heart rate. All exercise sessions were supervised in the research unit. Subjects wore a POLAR (S610; Polar Electro Oy, Kempele, Finland) heart rate monitor during each exercise session. To account for changes in fitness and body weight, a submaximal VO 2 max test was performed at wk 4 and 8 to recalculate the exercise duration needed to induce a 500 kcal energy deficit.
VO 2 max measurement
VO 2 max was measured during uphill treadmill walking or running (PPS 55 Med; Woodway, Munich, Germany), using the system Oxigen Pro (Viasys Healthcare, Hoechberg, Germany). A warm-up period of 10 min (50 -60% of maximum heart rate) preceded the test. A plateauing of oxygen uptake, despite increased work load and a respiratory exchange ratio of at least 1.05 were used as criteria for VO 2 max. Heart rate was measured during the test (Polar type 610; Polar Electro Oy), and maximal heart rate was defined by adding five beats per minute to the highest heart rate value obtained during the VO 2 max test.
Body composition
Body composition was measured using dual-energy x-ray absorptiometry (Hologic Discovery-A; Integrity Medical Systems Inc., Fort Myers, FL).
Resting metabolic rate (RMR)
RMR was measured by indirect calorimetry (Deltatrac II metabolic monitor; Datex-Ohmeda Division, Helsinki, Finland) with the participants fasted and laying supine for 30 min under a ventilated hood. Respiratory quotient was calculated as the ratio of carbon dioxide produced to oxygen consumed.
Habitual food intake
Participants were asked to maintain their normal diet throughout the study. This was verified by a 3-d estimated food diary (including at least one weekend day) using appropriate photographic booklets and household measures to improve the validity of portion size estimates, before the start of the study and at wk 12 of the exercise intervention.
Blood sampling and subjective measures of appetite
Participants visited the research unit in the fasted state (at least a 12-h fast), before and after the 12-wk exercise intervention (at least 48 h after the last exercise session to exclude acute effects of exercise). On each occasion, an iv cannula was inserted into an antecubital vein. Two fasting baseline blood samples (Ϫ10 and 0 min) were taken, and participants were asked to rate their baseline appetite using visual analog scales (VAS). Participants were then instructed to consume a standard breakfast [time (t) ϭ zero] (consisting of bread, orange juice, milk, cheese, and jam: 600 kcal, 17% protein, 35% fat, 48% carbohydrate) within 10 min. Blood samples were taken at regular intervals for a period of 3 h (every 15 min in the first hour and every half hour in the second and third hours), and subjective appetite was assessed throughout the morning using VAS. Subjective feelings of hunger ("how hungry do you feel?"), fullness ("how full do you feel?"), desire to eat ("how much would you like to eat?") and prospective food consumption ("how much do you think you can eat?") were assessed using 10-cm self-rated VAS, as previously described (14), before and after breakfast and at every half hour up to 3 h.
Hormone measurement
Venous blood was collected into potassium-oxalate tubes for analysis of glucose and potassium/EDTA-coated tubes containing 500 KIU aprotinin (Pentapharm, Basel, Switzerland)/ml whole blood for the measurement of insulin and gut peptides. Samples were then centrifuged at 2000 ϫ g for 10 min and plasma analyzed immediately (for glucose) or kept at Ϫ20 C for later analyses. For the measurement of AG, 50 l of a 1 N hydrochloric acid solution and 10 l of phenylmethylsulfonyl fluoride (Sigma, Schnelldorf, Germany) (10 mg/ml of isopropanol) were added to each milliliter of plasma immediately after centrifugation. All samples were batch-analyzed at the end of the study to reduce interassay variability.
Glucose was measured using standard laboratory techniques. Insulin, TG, and AG were quantified using human-specific RIA kits (Linco Research, St. Charles, MO) and GLP-1 and PYY "in-house" RIA methods (15, 16) . The sensitivity of the assays was 14 pmol/liter for insulin, 93 pg/ml for TG, 7.8 pg/ml for AG, 1 pmol/liter for GLP-1, and 2 pmol/liter for PYY. All samples were assayed in duplicate, and baseline and end samples of the same individual were analyzed in the same batch. The intraassay coefficient of variation was less than 10% for insulin, TG, and AG and less than 5% for GLP-1 and PYY.
Measurement of insulin sensitivity
Fasting insulin sensitivity, as a percentage of a normal reference population, was calculated using the HOMA2 Calculator version 2.2 (University of Oxford, Oxford, UK) (17).
Statistical analysis
Statistical analysis was carried out using SPSS 15.0 (SPSS Inc., Chicago, IL). All variables were checked regarding their normal distribution using the Shapiro-Wilk test. Statistical significance was assumed at P Ͻ 0.05, unless otherwise stated.
Differences in fasting plasma levels of metabolites/hormones and subjective feelings of appetite between the two blood sampling mornings (before and after the exercise intervention) were assessed by paired sample t tests. The effect of time and exercise (pre-vs. postintervention) on postprandial levels of metabolites/ hormones and subjective feelings of appetite were assessed by a repeated measures ANOVA. Amplitude of variation for appetite-related hormones was calculated as peak minus nadir. For TG and AG, nadir was defined as the single lowest value after breakfast and peak as the single highest value preceding breakfast (average fasting plasma level). For GLP-1 and PYY, nadir was average fasting plasma levels, and peak was the single highest value after breakfast.
The area under the curve (AUC) for plasma levels of appetiterelated hormones and subjective feeling of appetite was calculated from before to 180 min after breakfast using the trapezoidal rule. The effect of the exercise intervention on the AUC of each subjective feeling of appetite was assessed used paired sample t tests. Pearson (or Spearman) correlations were used to test the relationship between changes in the plasma levels of the hormones measured, changes in subjective feelings of appetite, and weight loss.
Results
Seven women did not complete the exercise program for several reasons including pregnancy, injury, and time constraints. No significant differences in baseline BMI or fitness levels (VO 2 max in ml/kg/min) were observed between completers and noncompleters. Results are presented for 15 subjects (seven women and eight men) with a mean age of 36.9 Ϯ 8.3 yr.
Exercise compliance
Participants who completed the intervention exercised at least 80% of the expected sessions (average, 89 Ϯ 5.9%).
Anthropometry, body composition, RMR, fitness levels, and eating behavior
Changes in anthropometry, body composition, RMR, and fitness levels in the 15 participants who completed the study are shown in Table 1 . There was a significant reduction in body weight, BMI, percentage body fat, total fat mass, and RMR and a significant increase in VO 2 max after the 12 wk of exercise (t ϭ 9.46, df ϭ 14, P Ͻ 0.0001; t ϭ 9.11, df ϭ 14, P Ͻ 0.0001; t ϭ 4.65, df ϭ 14, P Ͻ 0.0001; t ϭ 7.981, df ϭ 14, P Ͻ 0.0001; t ϭ 2.297, df ϭ 14, P Ͻ 0.05; and t ϭ Ϫ5.68, df ϭ 14; P Ͻ 0.0001, respectively), but no change in total fat-free mass (FFM) (t ϭ 1.344; df ϭ 14; P ϭ 0.2).
Habitual energy and macronutrient intake
There were no significant changes in energy (2252 Ϯ 569 vs. 2228 Ϯ 667 kcal; t ϭ 0.17; df ϭ 14; P Ͼ 0.05 or macronutrient intake, assessed by the 3-d food diaries, with the exercise intervention.
Plasma metabolites and hormones and insulin sensitivity
Fasting plasma levels and insulin sensitivity
One outlier was removed due to abnormally high levels of AG plasma levels at baseline [214.5 pmol/liter for fasting and 44,655 pmol/liter⅐min for postprandial total AUC (3.4 and 3.5 SD values away from the mean, respectively)]. The fasting plasma levels of the metabolites and hormones measured and insulin sensitivity, before and after the 12-wk exercise intervention, are displayed in Table 2 .
The exercise intervention resulted in a significant reduction in insulin and a significant increase in AG fasting plasma levels (t ϭ 3.49, df ϭ 14, P ϭ 0.004; t ϭ Ϫ2960, df ϭ 13, P ϭ 0.011, respectively), but no significant changes in glucose, TG, GLP-1, or PYY fasting plasma levels. The exercise intervention resulted also in a signif-icant increase in fasting insulin sensitivity (t ϭ Ϫ5.37; df ϭ 13; P Ͻ 0.0001).
Postprandial plasma levels
Glucose and insulin. A significant main effect of time [F(1.720, 17.197) ϭ 9.951; P Ͻ 0.0001], but no effect of exercise or interaction, was observed on glucose plasma levels, which increased from breakfast until t ϭ 30 min and decreased afterward (data not shown). A significant effect of time [F(1.895, 23.819) ϭ 25.53; P Ͻ 0.0001] and exercise (P Ͻ 0.05), but no interaction, was observed in insulin plasma levels (Fig. 1 ). Insulin plasma levels increased from breakfast until t ϭ 45 min and decreased afterward and were significantly lower after the exercise intervention.
Appetite-related hormones.
A significant main effect of time [F(7,91) ϭ 21.565; P Ͻ 0.0001], but no effect of exercise or interaction, was observed on TG plasma levels, which decreased from breakfast until t ϭ 90 min and increased progressively afterward (Fig. 2) . The amplitude of change in TG plasma levels (peak Ϫ nadir) increased, on average, 30% with the exercise intervention (204 Ϯ 123 vs. 261 Ϯ 151 pmol/liter), but this was not significant (t ϭ Ϫ1.519; df ϭ 14; P ϭ 0.151). Results are expressed as means Ϯ SD.
Means sharing the same symbol denote significant differences between baseline and end: a P Ͻ 0.05; b P Ͻ 0.0001. Means sharing the same symbol denote significant differences between baseline and end: a P Ͻ 0.05; b P Ͻ 0.01; c P Ͻ 0.0001. No significant effects of time, exercise, or exercise ‫ء‬ time interaction were observed on AG plasma levels (Fig.  2) . However, a closer analysis of the data revealed no significant effect of time at baseline between fasting at t ϭ 90 min [F(2.57, 30.79) ϭ 3.14; P ϭ 0.05], but a significant effect of time (suppression) at the end of the intervention [F(1.62, 19.42) ϭ 9.79; P ϭ 0.002]. Moreover, a significant increase (127%) in the amplitude of change in AG plasma levels (peak Ϫ nadir) was observed with the exercise intervention (12.4 Ϯ 11.1 vs. 28.1 Ϯ 21.4 pmol/liter; t ϭ Ϫ3.061; df ϭ 13; P ϭ 0.009).
A significant effect of time [F(2.599, 33.781) ϭ 12.839; P Ͻ 0.0001], but no main effect of exercise or interaction was observed on GLP-1 plasma levels (Fig. 3) . Total GLP-1 AUC (fasting up to 180 min) did not change with the exercise intervention, but there was a tendency for a higher GLP-1 AUC on the last 90 (90 -180 min) and 60 postprandial minutes (120 -180 min) after the 12-wk exercise intervention compared with baseline (1491 Ϯ 365 vs. 1689 Ϯ 430 pmol/liter⅐min, t ϭ Ϫ2.242, df ϭ 14, P ϭ 0.042; and 991 Ϯ 231 vs. 1126 Ϯ 248, t ϭ Ϫ2.388, df ϭ 14, P ϭ 0.032, respectively).
A significant effect of time [F(3.291, 42.789) ϭ 10.802; P Ͻ 0.0001], but no effect of exercise or interaction, was observed on PYY plasma levels (Fig. 3) . Total PYY AUC (fasting up to 180 min) did not change with the exercise intervention, but there was a tendency for higher PYY AUC between 120 and 180 min after the 12-wk exercise intervention compared with baseline (798 Ϯ 224 vs. 888 Ϯ 211; t ϭ Ϫ1.770; df ϭ 14; P ϭ 0.099).
Subjective feelings of appetite
Fasting state
There was a significant increase in fasted subjective feelings of hunger (4.1 Ϯ 1.6 vs. 6.5 Ϯ 2.5 cm; t ϭ Ϫ3.126; df ϭ 14; P Ͻ 0.01), desire to eat (4.8 Ϯ 1.5 vs. 6.4 Ϯ 2.3 cm; t ϭ Ϫ2.604; df ϭ 14; P Ͻ 0.05), and prospective food consumption (6.0 Ϯ 1.6 vs. 7.1 Ϯ 2.0 cm; t ϭ Ϫ2.286; df ϭ 14; P Ͻ 0.05), and a significant reduction in fullness feelings (3.5 Ϯ 1.1 vs. 1.9 Ϯ 1.5 cm; t ϭ 3.261; df ϭ 14; P Ͻ 0.01) after the 12-wk exercise intervention.
Postprandial state
A significant effect of time [F(3.039, 42.553) ϭ 20.910; P Ͻ 0.0001] and exercise [F(1,14) ϭ 10.901; P Ͻ 0.01] was observed on subjective feelings of hunger, which increased after the 12-wk exercise intervention compared with baseline levels (Fig. 4) . A significant effect of time [F(3.425, 47.944) ϭ 30.693; P Ͻ 0.0001] and a time ‫ء‬ exercise interaction [F(3.908, 54.707) ϭ 4.319; P Ͻ 0.01], but no main effect of exercise, was observed on subjective feelings of fullness ( Fig. 4) . A significant effect of time [F(7,91) ϭ 16.724; P Ͻ 0.0001] and exercise [F(1,13) ϭ 5.517; P Ͻ 0.05] was also observed on subjective feelings of desire to eat, with a similar pattern to that described for hunger feelings (data not shown). A significant effect of time [F(2.716, 38.027) ϭ 17.846; P Ͻ 0.0001], but no main effect of exercise or interaction, was observed on subjective feelings of prospective food consumption (data not shown). Repeated measures ANOVA showed a significant effect of time (P Ͻ 0.0001; P ϭ 0.001), but no effect of exercise or interactions for both GLP-1 and PYY, respectively.
There was a significant increase in the total AUC for hunger (530 Ϯ 310 vs. 720 Ϯ 342 cm⅐min; t ϭ Ϫ2.920; df ϭ 14; P Ͻ 0.05) and desire to eat scores (601 Ϯ 352 vs. 794 Ϯ 375 cm⅐min; t ϭ Ϫ2.331; df ϭ 14; P Ͻ 0.05) with the exercise intervention, but no significant change in total AUC for fullness (988 Ϯ 375 vs. 1001 Ϯ 324 cm⅐min; t ϭ Ϫ0.149; df ϭ 14; P Ͼ 0.05) or prospective food consumption (937 Ϯ 460 vs. 998 Ϯ 396 cm⅐min; t ϭ Ϫ0.805; df ϭ 14; P Ͼ 0.05).
Relationships among weight loss changes, subjective appetite sensations, and plasma levels of appetite-related hormones
There was a large variability in exercise-induced weight loss and body composition changes: fat mass (FM) and FFM, ranging from Ϫ5.9 to Ϫ1.2 kg for body weight, Ϫ5.2 to Ϫ0.6 kg for FM, and Ϫ4.0 to ϩ2.7 kg for FFM. Weight loss was not correlated with baseline (pre-intervention) appetite sensations or appetite-related hormone plasma levels or with the changes experienced in response to the exercise program.
Discussion
To the best of our knowledge, this is the first study to assess the impact of a medium-term supervised exercise program on fasting and postprandial plasma levels of both orexi-genic (TG and AG) and anorexigenic (GLP-1 and PYY) peptides involved in appetite control in sedentary overweight/obese individuals. We have shown that although 12 wk of exercise, inducing an average 3.5-kg weight loss, significantly increased fasting AG plasma levels and subjective feelings of hunger, it also led to a tendency for an increase in late postprandial release of GLP-1 and a significant increase in the amplitude of change of AG in response to a fixed meal. It is important to note that because participants were asked not to alter their food intake, some dietary restraint was exerted, which in turn could have contributed to the outcome. Therefore, the observed changes could not be attributed exclusively to exerciseinduced weight loss. Moreover, although it can be argued that the test meal used might not have been large enough to induce significant changes in appetite-related hormones, the energy content of our test meal was higher than that used in other appetite studies (18, 19) .
Previous studies on the impact of exercise-induced weight loss on appetite-related hormones have reported an increase (8 -10) or no change in fasting TG plasma levels (20) and no change in fasting AG plasma levels (10, 11) ; however, none had previously measured simultaneously changes in fasting and postprandial plasma levels of TG and AG in overweight and obese adults. Moreover, the only available studies on the impact of chronic exercise on the release of satiety peptides are limited by their short duration (5 d of exercise) (12) and absence of postprandial blood sampling (11) . The fact that in these two studies no significant change in body weight were observed (11, 12) makes it difficult to compare with the results of the present investigation.
We hypothesize that the type and magnitude of counterregulatory adaptations in response to weight loss are likely to differ, depending on the type of weight loss intervention. There is some evidence to suggest that dietinduced weight loss is associated with a compensatory increase in TG plasma levels and a blunted postprandial release of PYY and GLP-1 (6, 19) . Our findings suggest that exercise-induced changes are different. Exercise-induced weight loss may increase the drive to eat, as shown by increased levels of AG and subjective feelings of hunger in fasting, but it may also improve satiety consistent with the tendency toward an increase in the late postprandial release of GLP-1. These findings are in line with our previous observation that although medium-term exerciseinduced weight loss increases both fasting hunger and hunger across the day, it also improves the satiety efficiency of a breakfast (as shown by a significant increase in the satiety quotient) (21) . Moreover, we have shown here that the suppression of TG and AG in response to food intake (calculated as amplitude: peak Ϫ nadir) increases with exercise, although only significantly for AG. The increase in the amplitude of change of AG observed with the exercise intervention was due to the increase in fasting AG and not to a more pronounced decrease after the breakfast meal. However, it is important to acknowledge that before the exercise intervention, when participants were sedentary, AG plasma levels were irresponsive to food intake. This pattern was changed after 12 wk of exercise with an associated 3.5-kg average weight loss. Unfortunately, reports on the impact of weight loss or changes in physical activity levels on the postprandial release of AG are limited, and from our knowledge only one study has looked at the role of body weight on AG postprandial secretion (18) . Zwirska-Korczala et al. (18) reported a significant suppression of AG after the ingestion of a mixed meal in normal-weight women, but not in moderately or morbidly obese women with the metabolic syndrome. These findings are consistent with our results and suggest that obesity is characterized by the maintenance of high levels of AG which may supply a constant feeding drive in these individuals. We have shown that this "abnormal" pattern can be changed with exercise-induced weight loss.
We have also previously reported that exercise improves the ability to adjust EI according to previous food consumption (energy compensation) in both normal-weight (22) and overweight/obese sedentary individuals (Martins, C., B. Kulseng, N. A. King, and J. E. Blundell, submitted for publication). These findings suggest that sedentary individuals suffer from a malfunctioning or insensitive appetite control system that can be ameliorated by exercise.
Another important outcome of this study was the fact that the increase in fasting AG plasma levels and hunger (as well as other appetite) sensations, in response to the 12-wk exercise program, were unrelated to the magnitude of weight loss. This finding challenges the hypothesis that these changes are part of a homeostatic compensatory mechanism to restore EB. If this was the case, these changes would be expected to increase with the magnitude of weight loss. However, we are aware that our study has a small sample size and more power is required to detect such associations. Moreover, because all our participants lost weight with the exercise intervention, it is difficult to speculate whether the observed changes were a result of weight loss or exercise per se. Only a study with sufficient power and where exercise is performed in EB (by matching the energy costs of exercise with an equivalent increase in EI) and energy deficit can clearly establish whether the increase in fasting hunger feelings and AG plasma levels is a result of weight loss (and therefore part of a compensatory homeostatic mechanism) or exercise.
We can conclude that although exercise-induced weight loss leads to an increase in fasting AG and hunger sensations, similar to what has been reported in response to dietary-induced weight loss, exercise appears to balance this increased orexigenic drive by improving the satiety response to a meal and the sensitivity of the appetite control system.
